NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · USD

Revelation Biosciences, Inc. (REVBW) Stock Analysis

Revelation Biosciences, Inc. (REVBW) is a stock listed on NASDAQ and quoted in US Dollar.

REVBW

$0.01

−$0.00 (−2.99%)

Last trade August 24, 2026

This is a derivative instrument — a warrant on Revelation Biosciences, Inc. (REVB) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View REVB →

Price History

Hover for the daily close. The dotted line marks the period open.

REVBW Key Statistics

As of Aug 24, 2026
Trading
Open
$0.01
Previous Close
$0.01
Day's Range
0.01–0.01
52-Week Range
0.01–0.01
Volume
60
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.14

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

REVBW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−36.27%
2025 (partial year)+0.00%

As of August 24, 2026.

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Visit website →